Pharmaceuticals: Jordan | Future | Growth | Prospects | Challenges

Pharmaceutical Industry in Jordan: Market Overview and Registration Process

Country Information

Capital: Amman (Population: 2.5 million in 2006).

Main Port: Port of Aqaba.

Population (2021): 10.23 million (including Palestinian, Syrian, and Iraqi refugees).

Top 5 Causes of Death (2019)

1. Ischemic heart disease
2. Stroke
3. Diabetes
4. Chronic kidney disease
5. Hypertensive heart disease

Economy

GDP (2020): USD 43.698 billion

GDP per capita (2020): 4,282 USD

GDP growth rate (2020): -1.55%

Gross National Income (GNI 2020): 10,320 USD (PPP)

Trade

Exports (2019): JD 4.99 billion, including food, livestock, unrefined materials, apparel, and plastic products.

Main Export Destinations: United States, Saudi Arabia, Iraq, Kuwait, UAE, India, and more.

Imports (2019): JD 13.72 billion, a 4.9% decrease from the previous year.

Pharmaceutical Market Status

Jordan's pharmaceutical industry imports most active pharmaceutical ingredients (API) from India and China, while excipients are primarily sourced from Europe.

80% of pharmaceutical products in Jordan are exported, with 20% for domestic use. The pharmaceutical sector is the second-largest export industry after garment manufacturing.

Jordan Drug Registration Process

Drug registration in Jordan involves submitting documentation on the drug’s chemical composition, clinical data, manufacturing facility, and other technical aspects.

Registration generally takes about a year, and the drug must be approved for sale in its country of origin or a JFDA reference country.

Jordan FDA official website: http://www.jfda.jo